News & Updates

Show Multimedia Only

Two-year data support brolucizumab for diabetic macular oedema

17 May 2024 by

The 100-week results of the phase III KESTREL and KITE studies reflect the long-term efficacy and durability of brolucizumab in improving visual and anatomical outcomes in patients with diabetic macular oedema (DMO).

Two-year data support brolucizumab for diabetic macular oedema

17 May 2024

Trabeculectomy helps stabilize visual function in glaucoma patients

08 May 2024

Vision-related quality of life (VR-QoL) in patients with glaucoma who underwent trabeculectomy remains unchanged before and after the procedure, which indicates the stabilizing effect of trabeculectomy on both objective and subjective visual function, according to a study.

Trabeculectomy helps stabilize visual function in glaucoma patients

08 May 2024

Is topical better than standard steroid after cataract surgery?

07 May 2024

Soft topical steroid application and standard steroid treatment demonstrate similar efficacy and safety in patients who underwent cataract surgery, reports a study.

Is topical better than standard steroid after cataract surgery?

07 May 2024

Multiple sensory impairment in older Asians takes toll on functional capacity, healthcare spending

06 May 2024 by

One in five older adults in Singapore sustain multiple sensory impairment (MSI), which can lead to the loss of functional independence and mobility while imposing a substantial economic burden, according to the PIONEER study.

Multiple sensory impairment in older Asians takes toll on functional capacity, healthcare spending

06 May 2024

Is omega-3 fatty acid protective against diabetic retinopathy?

06 May 2024

Daily intake of omega-3 fatty acids (FA) 1 g appears to confer no clinically meaningful benefit on diabetic retinopathy (DR), reveals a study.

Is omega-3 fatty acid protective against diabetic retinopathy?

06 May 2024

Aflibercept injection a promising treatment for ROP in preterm infants

05 May 2024

Intravitreal aflibercept therapy appears to be safe and efficacious in the management of retinopathy of prematurity (ROP) through 2 years of age when compared with laser therapy in children who are born preterm or with low birth weight, according to 2-year data from the nonrandomized FIREFLYE trial.

Aflibercept injection a promising treatment for ROP in preterm infants

05 May 2024

Visual impairment tied to heightened risk of suicidal tendencies among teens

24 Apr 2024

People with visual impairment may have increased suicidal tendencies, and this association is especially pronounced among adolescents, according to the results of a systematic review and meta-analysis.

Visual impairment tied to heightened risk of suicidal tendencies among teens

24 Apr 2024

NSAIDs, combination therapies safe, effective for cataract surgery aftercare

05 Apr 2024

Nonsteroidal anti-inflammatory drugs (NSAIDs) and combination treatments provide a more effective and safer alternatives to corticosteroid in the postoperative management of patients who have undergone cataract surgery, according to a study.